Connect your AI

Janux Therapeutics JANX Price / book

Price / book at other companies

Johnson & JohnsonJNJ

7.3×+2.1×

AmgenAMGN

20.6×-6.3×

Regeneron PharmaceuticalsREGN

2.6×+0.2×

XencorXNCR

1.7×+0.5×

AbbVieABBV

261×+221×

Vor BiopharmaVOR

1.4×0.0×

Other financials

Income statement

Revenue$3.7M—

Operating income-$34.2M+2.0%

Net income-$24.4M-3.6%

EPS (diluted)-$0.39-2.6%

Balance sheet

Cash & equivalents$51.8M-29.7%

Total debt$21.6M-4.6%

Total equity$941.5M-7.0%

Total assets$1.0B-2.1%

Cash flow

Operating cash flow-$12.3M+27.5%

CapEx$273.0K-26.4%

Free cash flow-$12.6M+27.5%

Valuation

Market cap$889.15M-36.3%

Enterprise value$858.89M-36.2%

P/S64.8×-84.8×

Profitability

Operating margin-1,143.1%-65.1pp

Net margin-833.6%+0.9pp

FCF margin-571.6%+98.3pp

Returns & leverage

Return on equity-11.7%+4.1pp

Debt / equity0×0.0×

Current ratio17×-41.5×

Where this comes from

Calculated from Janux Therapeutics’s reported figures.

market cap/total stockholders equity=0.9×

Based on the most recent quarter.

The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Janux Therapeutics's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Janux Therapeutics's price / book?: Janux Therapeutics (JANX) reported price / book of 0.9× in Q1 2026.
How has Janux Therapeutics's price / book changed year-over-year?: Janux Therapeutics's price / book decreased by 43.0% year-over-year, from 1.6× to 0.9×.
What is the long-term trend for Janux Therapeutics's price / book?: Over 4 years (2021 to 2025), Janux Therapeutics's price / book has grown at a -21.0% compound annual growth rate (CAGR), from 2.2× to 0.9×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.